日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of Adjuvant Alectinib Versus Chemotherapy for Patients with Resectable, ALK-positive Non-small Cell Lung Cancer in Canada

在加拿大,辅助阿来替尼治疗与化疗治疗可切除的ALK阳性非小细胞肺癌患者的成本效益分析

Jovanoski, Nick; Vaselenak, Sarah; Hogan, Andrew; Turki, Jasmine; Chu, Quincy

The long-term avoided recurrences and recurrence-related cost of alectinib for postoperative adjuvant therapy in Chinese patients with early-stage ALK-positive non-small cell lung cancer

阿来替尼用于中国早期ALK阳性非小细胞肺癌患者术后辅助治疗的长期预防复发率及复发相关成本

Yan, Xuanxuan; Zhou, Sijuan; Hu, Jiahao; Xia, Yan; He, Haotian; Jovanoski, Nick; Arnold, Melina; Hu, Jian; Song, Pingping; Jiang, Benyuan; Zhang, Yong; Lu, Jingwen; Wu, Yilong; Ying, Xiaohua

Treating moderate to severe menopausal vasomotor symptoms with fezolinetant: responder analysis of the phase 3b DAYLIGHT study

使用非唑利坦治疗中重度更年期血管舒缩症状:3b期DAYLIGHT研究的应答者分析

Jovanoski, Nick; Kuznik, Andreas; Becker, Ursula; Hussein, Mohamed; Briggs, Andrew; Shapiro, Marla; Schaudig, Katrin; Hirschberg, Angelica Lindén; Blogg, Martin; Morga, Antonia; Martins, Karla; Bouchard, Céline

Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada

辅助阿特珠单抗治疗对加拿大 II-IIIA 期非小细胞肺癌患者避免复发和节省治疗费用的影响

Chu, Quincy; Sripada, Kaushik; Vaselenak, Sarah; Jovanoski, Nick; Arnold, Melina

Dopaminergic systems create reward seeking despite adverse consequences

多巴胺能系统促使人们即使面临不利后果也依然寻求奖励。

Jovanoski, Kristijan D; Duquenoy, Lucille; Mitchell, Jessica; Kapoor, Ishaan; Treiber, Christoph D; Croset, Vincent; Dempsey, Georgia; Parepalli, Sai; Cognigni, Paola; Otto, Nils; Felsenberg, Johannes; Waddell, Scott

Publisher Correction: Dopaminergic systems create reward seeking despite adverse consequences

出版商更正:多巴胺能系统会在产生不良后果的情况下引发寻求奖励的行为。

Jovanoski, Kristijan D; Duquenoy, Lucille; Mitchell, Jessica; Kapoor, Ishaan; Treiber, Christoph D; Croset, Vincent; Dempsey, Georgia; Parepalli, Sai; Cognigni, Paola; Otto, Nils; Felsenberg, Johannes; Waddell, Scott

Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)

系统性文献综述,旨在确定早期非小细胞肺癌(NSCLC)患者的成本和资源利用数据

Jovanoski, Nick; Abogunrin, Seye; Di Maio, Danilo; Belleli, Rossella; Hudson, Pollyanna; Bhadti, Sneha; Jones, Libby G

Photocatalytic Activity of the V2O5 Catalyst toward Selected Pharmaceuticals and Their Mixture: Influence of the Molecular Structure on the Efficiency of the Process

V2O5 催化剂对选定药物及其混合物的光催化活性:分子结构对过程效率的影响

Sanja J Armaković, Aleksandra Jovanoski Kostić, Andrijana Bilić, Maria M Savanović, Nataša Tomić, Aleksandar Kremenović, Maja Šćepanović, Mirjana Grujić-Brojčin, Jovana Ćirković, Stevan Armaković

Cost-effectiveness of adjuvant atezolizumab for patients with stage II-IIIA PD-L1+ non-small-cell lung cancer

阿特珠单抗辅助治疗对II-IIIA期PD-L1阳性非小细胞肺癌患者的成本效益分析

Das, Millie; Ogale, Sarika; Jovanoski, Nick; Johnson, Ann; Nguyen, Caroline; Bhagwakar, Jan; Lee, Janet S

Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review

早期非小细胞肺癌患者健康状态效用值:系统性文献综述

Jovanoski, Nick; Abogunrin, Seye; Di Maio, Danilo; Belleli, Rossela; Hudson, Pollyanna; Bhadti, Sneha; Jones, Libby G